Kenneth A. Bauer
Corporate Officer/Principal bei The International Society of Thrombosis & Hemostasis
Profil
Kenneth A.
Bauer has been a Director of GTC Biotherapeutics, Inc. since December 2004, Director of Thrombosis Clinical Research for the Beth Israel Deaconess Medical Center since 1997 and Professor of Medicine at the Harvard Medical School since 2004.
Dr. Bauer has been a Faculty Member of the Harvard Medical School since 1982.
He is Chairman of Council for the International Society on Thrombosis and Haemostasis.
He received a BS and an MS from the Massachusetts Institute of Technology and his Medical Education from the Stanford University School of Medicine.
He completed subspecialty training in medical oncology and hematology at the Dana Farber Cancer Institute and Beth Israel Hospital in Boston.
Aktive Positionen von Kenneth A. Bauer
| Unternehmen | Position | Beginn |
|---|---|---|
| The International Society of Thrombosis & Hemostasis | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Kenneth A. Bauer
| Unternehmen | Position | Ende |
|---|---|---|
| REVO BIOLOGICS INC | Direktor/Vorstandsmitglied | 01.10.2009 |
Beth Israel Deaconess Medical Center, Inc.
 Beth Israel Deaconess Medical Center, Inc. Hospital/Nursing ManagementHealth Services Beth Israel Deaconess Medical Center provides medical services. It offers patient care, biomedical research, teaching, and community services. It also provides organ transplantation, breast cancer care, and cardiac surgery services. The company was founded in 1896 and is headquartered in Boston, MA. | Corporate Officer/Principal | - |
Ausbildung von Kenneth A. Bauer
| Massachusetts Institute of Technology | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
rEVO Biologics, Inc.
 rEVO Biologics, Inc. BiotechnologyHealth Technology rEVO Biologics, Inc. engages in the development and commercialization of specialty therapeutics to address unmet medical needs in patients with rare, life-threatening conditions. Its products include ATryn, which prevents blood clots during and after surgery and childbirth for patients with hereditary antithrombin deficiency. The company was founded in February 1993 and is headquartered in Framingham, MA. | Health Technology |
Beth Israel Deaconess Medical Center, Inc.
Beth Israel Deaconess Medical Center, Inc. Hospital/Nursing ManagementHealth Services Beth Israel Deaconess Medical Center provides medical services. It offers patient care, biomedical research, teaching, and community services. It also provides organ transplantation, breast cancer care, and cardiac surgery services. The company was founded in 1896 and is headquartered in Boston, MA. | Health Services |
| The International Society of Thrombosis & Hemostasis |
